A cluster randomized controlled trial to evaluate the efficacy of esophageal and gastric cancer screening in mortality reduction in a non-high-incidence area: methodology and initial results.

MLA

Wang, Xiao-Yang, et al. “A Cluster Randomized Controlled Trial to Evaluate the Efficacy of Esophageal and Gastric Cancer Screening in Mortality Reduction in a Non-High-Incidence Area: Methodology and Initial Results.” Annals of Translational Medicine, vol. 10, no. 18, Sept. 2022, p. 994. EBSCOhost, https://doi.org/10.21037/atm-22-4052.

APA

Wang, X.-Y., Liu, S.-Z., Xu, H.-F., Liu, Y., Wang, H., Kang, R.-H., Chen, Q., Zhang, L.-Y., Guo, L.-W., Zheng, L.-Y., Liu, C.-Y., Wang, Y.-X., Jing, Y.-P., Qiao, Y.-L., Han, B.-B., & Zhang, S.-K. (2022). A cluster randomized controlled trial to evaluate the efficacy of esophageal and gastric cancer screening in mortality reduction in a non-high-incidence area: methodology and initial results. Annals of Translational Medicine, 10(18), 994. https://doi.org/10.21037/atm-22-4052

Chicago

Wang, Xiao-Yang, Shu-Zheng Liu, Hui-Fang Xu, Yin Liu, Hong Wang, Rui-Hua Kang, Qiong Chen, et al. 2022. “A Cluster Randomized Controlled Trial to Evaluate the Efficacy of Esophageal and Gastric Cancer Screening in Mortality Reduction in a Non-High-Incidence Area: Methodology and Initial Results.” Annals of Translational Medicine 10 (18): 994. doi:10.21037/atm-22-4052.